Suzuki Y, Uchida J, Tsuji H, Kuzuhara K, Hara S, Nihei H, Ogura Y, Otsubo O, Mimura N
Tohoku J Exp Med. 1987 May;152(1):35-45. doi: 10.1620/tjem.152.35.
Blood sample were collected from both the arterial and venous lines of the patients undergoing hemodialysis using cuprophan membrane at several time intervals. Radioimmunoassay was then applied to measure the C3a and C5a levels. C3a levels from the arterial lines of patients undergoing uneventful hemodialysis were 463.2 +/- 51.3 ng/ml (mean +/- S.D.), 1112.9 +/- 109.9, 956.0 +/- 72.1, and 721.2 +/- 49.6 at 0, 15, 120 and 360 min, respectively. C5a levels did not change significantly during uneventful hemodialysis. C3a and C5a levels were significantly higher in the blood from the venous lines than those from the arterial lines, a finding indicating that complement activation via alternative pathway takes place in the dialyzer. C3a and C5a levels were markedly elevated in patients with anaphylactoid reaction. Reuses of dialyzers on the patients having a history of an anaphylactoid reaction during hemodialysis suppressed not only the rise of C3a levels, but also the recurrence of the reaction. From these findings, it is concluded that rises of C3a and C5a in the arterial lines of patients are causally related to the induction of anaphylactoid reaction during hemodialysis.
在几个时间间隔,使用铜仿膜从接受血液透析患者的动脉和静脉管路采集血样。然后应用放射免疫分析法测量C3a和C5a水平。在平稳血液透析过程中,患者动脉管路的C3a水平在0、15、120和360分钟时分别为463.2±51.3 ng/ml(平均值±标准差)、1112.9±109.9、956.0±72.1和721.2±49.6。在平稳血液透析过程中,C5a水平没有显著变化。静脉管路血液中的C3a和C5a水平显著高于动脉管路中的水平,这一发现表明在透析器中通过替代途径发生了补体激活。类过敏反应患者的C3a和C5a水平明显升高。对有血液透析期间类过敏反应病史的患者重复使用透析器,不仅抑制了C3a水平的升高,也抑制了反应的复发。从这些发现可以得出结论,患者动脉管路中C3a和C5a的升高与血液透析期间类过敏反应的诱发存在因果关系。